Pliant Therapeutics PLRX Institutional Ownership

NASDAQ PLRX

$1.15 +0.01 (+1.32%)

At close: Sep 9, 2026 · 4:00 PM EDT

Institutions by Trading Activity

86 Institutions

Increased 28 32.6%

Unchanged 33 38.4%

Reduced 25 29.1%

Ownership Statistics

13F · as of 30 Jun, 2026

Institutional Ownership

77.68%

▼-0.01 pp QoQ

Shares Held by Institutions

48.10Mn

of 61.92Mn outstanding

▲+9.09% QoQ

Shares Outstanding

61.92Mn

13.82Mn held outside 13F filers

Institutional Investors

filed 13F for Jun 2026

▼-4 vs prior quarter

Net Shares Added (QoQ)

+4.01Mn

accumulated since last quarter

Value of Holdings

$55.80Mn

reported market value

Shares Owned by Institutions

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Institutions

Accumulated Distributed

Latest quarter —

Net over range —

Accumulating quarters —

Ownership Summary

Quarter ending 30 Jun, 2026

Pliant Therapeutics, Inc. (NASDAQ:PLRX) is held by 86 institutional investors per 13F filings through June 2026.

These investors collectively held 77.7% of Pliant Therapeutics's outstanding shares in June 2026, down from 77.7% in March 2026.
Their total shares held in PLRX increased 9.09% quarter over quarter, and separately, investors owning Pliant Therapeutics decreased 23.21% from a year ago.
Activity in PLRX broke down as 28 buyers, 25 sellers, and 33 unchanged among 86 total holders.
The aggregate institutional position in Pliant Therapeutics amounted to 48.1Mn shares as of June 2026, up by 4.01Mn shares quarter on quarter, and up 2.47Mn shares year over year.
As of June 30, 2026, TANG CAPITAL MANAGEMENT LLC held the largest stake in Pliant Therapeutics with 6.14Mn shares, accounting for 9.92% of total shares outstanding.
The most significant purchases of PLRX for the quarter ending June 2026 came from ADAR1 Capital Management, LLC (2.92Mn), Lynx1 Capital Management LP (1.8Mn), Prosight Management, LP (1.37Mn), Ikarian Capital, LLC (1.0Mn), BOOTHBAY FUND MANAGEMENT, LLC (303.0K).
The largest sellers of Pliant Therapeutics for the quarter ending June 2026 were CITADEL ADVISORS LLC (1.08Mn), MILLENNIUM MANAGEMENT LLC (621.07K), UBS Group AG (486.19K), Goldman Sachs Group Inc (388.25K), Woodline Partners LP (370.3K).
Per Business Quant data, the top 10 holders of Pliant Therapeutics for the quarter ending June 2026 are TANG CAPITAL MANAGEMENT LLC (6.14Mn), ADAR1 Capital Management, LLC (5.51Mn), VANGUARD CAPITAL MANAGEMENT LLC (2.44Mn), ACADIAN ASSET MANAGEMENT LLC (2.42Mn), TWO SIGMA INVESTMENTS, LP (2.26Mn), CITADEL ADVISORS LLC (2.14Mn), RENAISSANCE TECHNOLOGIES LLC (2.05Mn), Monaco Asset Management SAM (1.94Mn), Lynx1 Capital Management LP (1.8Mn), BML Capital Management, LLC (1.55Mn).

Form 13F Holdings

86 Institutional Holders

Report period 30 Jun, 2026

Total shares held 48.10Mn

Of outstanding 77.68%

#	Institution	CIK	Shares Held	% of Outstanding	Change (QoQ)	Change (%)	Value (USD)
1	TANG CAPITAL MANAGEMENT LLC	0001232621	6,141,261	9.92%	▼1,871	-0.03%	$7.00Mn
2	ADAR1 Capital Management, LLC	0001940272	5,509,724	8.90%	▲2,924,598	+113.13%	$6.28Mn
3	VANGUARD CAPITAL MANAGEMENT LLC	0002100119	2,440,351	3.94%	▲97,250	+4.15%	$2.78Mn
4	ACADIAN ASSET MANAGEMENT LLC	0000916542	2,416,508	3.90%	0	0.00%	$2.75K
5	TWO SIGMA INVESTMENTS, LP	0001179392	2,262,832	3.65%	▲9,694	+0.43%	$2.58Mn
6	CITADEL ADVISORS LLC	0001423053	2,142,226	3.46%	▼1,084,373	-33.61%	$2.44Mn
7	RENAISSANCE TECHNOLOGIES LLC	0001037389	2,049,874	3.31%	▲197,032	+10.63%	$2.34Mn
8	Monaco Asset Management SAM	0001803593	1,938,747	3.13%	0	0.00%	$2.21Mn
9	Lynx1 Capital Management LP	0001910456	1,798,070	2.90%	▲1,798,070	0.00%	$2.05Mn
10	BML Capital Management, LLC	0001616824	1,546,137	2.50%	0	0.00%	$1.76Mn
11	Prosight Management, LP	0001617201	1,370,233	2.21%	▲1,370,233	0.00%	$1.56Mn
12	Peapod Lane Capital LLC	0002050979	1,309,013	2.11%	▲20,435	+1.59%	$1.49Mn
13	Woodline Partners LP	0001784547	1,296,534	2.09%	▼370,296	-22.22%	$1.48Mn
14	BlackRock, Inc.	0002012383	1,151,214	1.86%	▲54,784	+5.00%	$1.31Mn
15	Ikarian Capital, LLC	0001778253	1,000,000	1.62%	▲1,000,000	0.00%	$1.14Mn
16	Eversept Partners, LP	0001697013	891,425	1.44%	0	0.00%	$1.02Mn
17	MARSHALL WACE, LLP	0001318757	835,124	1.35%	▼160,849	-16.15%	$952.04K
18	Redmile Group, LLC	0001425738	772,126	1.25%	0	0.00%	$880.22K
19	Jpmorgan Chase & Co	0000019617	681,647	1.10%	▼180,176	-20.91%	$783.89K
20	JACOBS LEVY EQUITY MANAGEMENT, INC	0000884414	643,120	1.04%	▼75,423	-10.50%	$733.16K

Showing 1 to 20 of 86 holders